Navigation Links
NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
Date:8/5/2009

al Flu vaccine."

"The accomplishments announced today further validate our strategy to create a rapid, in-border influenza vaccine solution for governments around the world by addressing gaps in currently available vaccine technologies," added Dr. Rahul Singhvi, President and CEO of Novavax, Inc.

Novavax, Inc has successfully completed a Phase I/IIa clinical study with a candidate H5N1 influenza VLP vaccine and is currently in Phase II trials with a VLP based seasonal flu vaccine candidate. The Company plans to initiate a Phase II study with its Seasonal Flu vaccine candidate in the elderly population during Q4, 2009.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology. The company produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the company's various filings with the Securities and Exchange Commission.

Forward Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding revenues, operating expenses, cash burn, and clinical developments and anticipated milestones are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the Company's ability to progress
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
2. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
3. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
4. Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
5. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
6. NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting
7. NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference
8. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
9. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
10. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
11. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... DALLAS , September 23, 2014 ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible ... Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to ... Market over the forecast period of 2014 to ... Billion by 2019, at CAGR of 9.6% from ...
(Date:9/23/2014)... , Sept. 23, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary focus on ... C. Shrotriya , MD, Chairman and Chief Executive Officer ... The appointment was made in connection with the recently ...
(Date:9/23/2014)... Sept. 23, 2014 Today, DripDrop, the first ... formation of the DripDrop Foundation, with its primary ... worldwide. Utilizing scientific advancements in Oral Rehydration Therapy ... reduce dehydration and healthcare costs through strategic partnerships, ... "DripDrop has been used in disaster ...
Breaking Medicine Technology:Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 4CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 2CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 3CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 4DripDrop Forms Foundation To Scale Relief Efforts 2
... Dec. 3, 2010 Sermo ( http://www.sermo.com ), the ... free Sermo Report titled, " Potential Replacements for Coumadin ... awareness and understanding of these products and potential barriers ... were aware that a new product, Pradaxa (dabigatran etexilate ...
... 3, 2010 VIVUS, Inc. (Nasdaq: ... present an overview of the company at two ... presentation schedule is as follows:Canaccord Genuity Cardiovascular, Diabetes ... PTNikko Hotel, San Francisco, CAPresenter: Charles Bowden, MD, ...
Cached Medicine Technology:Sermo Study shows 70% of Specialists are Ready to Replace Warfarin 2
(Date:9/23/2014)... The U.S. Pharmacopeial Convention (USP) has submitted ... (WHO) regarding the assignment of Biological Qualifiers (BQ) to ... Expert Group of the Programme of International Nonproprietary Names ... naming of all biologicals that is consistent with existing, ... these drugs. , Hence, USP supports the concept ...
(Date:9/23/2014)... Dotinga HealthDay Reporter MONDAY, Sept. ... four out of five heart attacks in men, a new study ... to have heart attacks over an average of 11 years if ... diet, exercise and weight fronts, the study found. Only ... this ultra-healthy-living category. But they were 86 percent less likely to ...
(Date:9/23/2014)... California (PRWEB) September 23, 2014 With ... items, World Gardens Café has added Vegan as an ... come fully prepared and frozen – perfect for busy ... as a fast food meal, these healthy alternatives are ... menu includes meals such as Adobe Tempeh, Caribbean Vegetable ...
(Date:9/23/2014)... CA (PRWEB) September 23, 2014 Fountain Valley ... has won their latest body transformation contest and been named ... “Jennifer was raised here in Fountain Valley and still resides ... since June 2014 and she recently signed up for one ... been phenomenal,” says owner Zenia Joyner. “In just six weeks, ...
(Date:9/23/2014)... Recently, Best Cheap Hosting USA, a popular review ... best VPS hosting suppliers in the current market. Among ... hosting is a very popular. The account owner is ... others’ websites under his name, brand or company. , ... primary hosting plans (reseller hosting and low cost shared ...
Breaking Medicine News(10 mins):Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 2Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 3Health News:World Gardens Café Announces Launch of New Vegan Menu 2Health News:Fountain Valley Fit Body Boot Camp Announces Winner of Fitness Boot Camp Ambassador Contest 2Health News:Best Cheap Hosting USA: Bluehost And JustHost Are Ranked As The Best VPS Hosting Suppliers 2
... of the wellbeing and inclusion of former politically motivated ... University today (Monday 14 March). Ageing and ... Ireland and the border region of Ireland investigated the ... and republican former prisoners (aged 50 and over) as ...
... (March 14, 2011) Research has shown that playing a ... children, but playing a used instrument also can pose a ... instruments were found to be heavily contaminated with a variety ... minor to serious infectious and allergic diseases, according to a ...
... , MONDAY, March 14 (HealthDay News) -- Watching this year,s ... for those who bet on the games, one expert suggests. ... sites and spoiler message boards seems to suggest that predicting ... according to Stephen M. Nowlis, a marketing professor at the ...
... numerous paths to resist the targeted drug Herceptin, but ... a tumor,s vulnerability to treatment, scientists at The University ... at Nature Medicine . Adding the drug ... cutting off at least five different molecular pathways, each ...
... March 11 (HealthDay News) -- People would prefer to allow ... they know others are watching, says a new study. ... think badly of them if they do something wrong rather ... research in the journal Psychological Science . "Omissions ...
... (HealthDay News) -- A doctor,s empathy can improve the care ... of being a good doctor, according to a new study. ... 2006 and June 2009 by 29 doctors at Thomas Jefferson ... of empathy for patients, while the quality of patient care ...
Cached Medicine News:Health News:Report into well-being and inclusion of former politically motivated prisoners 2Health News:Report into well-being and inclusion of former politically motivated prisoners 3Health News:Is your child's hobby making him sick? 2Health News:Combination overcomes breast cancer resistance to herceptin 2Health News:Combination overcomes breast cancer resistance to herceptin 3Health News:When Someone Is Watching, You're Less Inclined to Do Bad Things 2
Whether you require high flow rates for critical situations or lower rates for others, this insufflator handles both situations equally well, regulated by the preselected pressure....
The TurboFlow 8000 has two separate gas output ports which, unlike many high flow insufflators, use standard-size tubing, each capable of providing up to 20 LPM flow....
Tongs...
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
Medicine Products: